CYTH logo

Cyclo Therapeutics, Inc. Common Stock


CYTH: Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquaplex.


Show CYTH Financials

Consumer Interest
SEC Filings

Recent trades of CYTH by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by CYTH's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of CYTH in WallStreetBets Daily Discussion


Recent insights relating to CYTH

CNBC Recommendations

Recent picks made for CYTH stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in CYTH

Corporate Flights

Flights by private jets registered to CYTH